4 articles
Zacks Research downgraded Chemours to 'Strong Sell' following missed quarterly earnings estimates for EPS and revenue. Analyst consensus remains Hold with a $21 price target despite the recent downgra
Chemours Co CFO Shane Hostetter bought 3,350 shares at $14.94, boosting direct ownership to over 102,000 shares. This transaction signals insider confidence while the stock remains modestly undervalue
Chemours Co CFO Shane Hostetter acquired 3,350 shares at $14.94 per share on August 6, increasing his beneficial ownership to 102,697 shares.
Chemours CFO Shane Hostetter targets $250 million in cost reductions by 2027 with an adjusted EBITDA forecast of $800-$900 million. He addressed PFAS liabilities, tariff benefits for Titanium Technolo
ChemBrief